To further assess the significance of nucleotide de novo synthesis for breast cancer metastasis, we specifically silenced Prps2, a key enzyme catalyzing the first reaction in nucleotide synthesis, which was highly up-regulated in metastatic cells [19] (Fig 3A and 3B). The gene discussed is PRPS2; the disease is breast carcinoma.